Indefinite Delivery Contract 75N93020D00004
Award Date
2/1/20
Last Date to Order
1/31/27
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Cost No Fee
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award Indefinite Delivery Contract (IDC) worth up to $146.3M to the University of South Alabama to provide pre-clinical models of infectious diseases. The contract has a 7-year ordering period ending on July 14, 2031. The IDC comprises four task areas focused on developing and refining small animal, non-human primate, and non-traditional/animal replacement models to evaluate candidate countermeasures (e.g....
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to FHI Clinical Inc. to provide comprehensive and rapid response research programs. The contract has a potential value of $545,452,906 over a seven-year ordering period through August 2028. Two task orders have been issued against it to date, one for $332,178 and another for $2,000. Under the contract, FHI Clinical Inc. will support the NIAID's mission to conduct biomedical research on infectious,...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Emory University to support research efforts from March 2020 through March 2027. Task orders issued against this IDV include delivery of unspecified research services and products related to advancing the understanding and treatment of allergies and infectious diseases. Task order values range from approximately $18,000 to over $11.5 million, with total potential...
The National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Camris International, LLC to support biomedical research programs. The contract vehicle has a potential value of $545,452,906 to be obligated against through task orders over a seven-year ordering period ending August 2028. Two task orders have been awarded to date under the contract: one for $545,232 for current good manufacturing practice process development of a trachoma vaccine in Bethesda,...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a single-award, $146.3M Indefinite Delivery Contract to Trustees of Tufts College, doing business as Tufts University School of Medicine, to provide pre-clinical research and development services related to infectious disease models. The contract has a 7-year ordering period and aims to support NIAID's Division of Microbiology and Infectious Diseases in developing and refining animal and animal replacement models for...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to PPD Development LP with a potential value of $545,452,906 to provide comprehensive and rapid response capabilities for research programs through September 2028. Task orders issued against the contract include over $132 million for clinical trial management support services relating to COVID-19, as well as orders valued at $2.33 million, $2 million, and $82.5...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract valued up to $146,300,000 to Southern Research Institute, a non-profit research organization, to develop and employ animal and animal replacement models of infectious diseases. The contract will support screening, product evaluation, and eventual clinical evaluation of vaccines, therapeutics, and...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract (IDC) valued at $146,300,000 to The Administrators of the Tulane Educational Fund, doing business as Tulane University. The contract covers a 7-year ordering period and aims to provide preclinical research support services to facilitate the development of medical countermeasures, including animal studies,...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to International Aids Vaccine Initiative Inc. to provide preclinical services supporting the development of biopharmaceutical therapeutics and diagnostics for infectious diseases. The potential value of the contract is $30 million with a performance period from January 2023 through September 2030. Services will be delivered under five task areas: product...